CENTRAL D2-DOPAMINE RECEPTOR OCCUPANCY IN RELATION TO ANTIPSYCHOTIC DRUG EFFECTS - A DOUBLE-BLIND PET STUDY OF SCHIZOPHRENIC-PATIENTS

被引:422
作者
NORDSTROM, AL [1 ]
FARDE, L [1 ]
WIESEL, FA [1 ]
FORSLUND, K [1 ]
PAULI, S [1 ]
HALLDIN, C [1 ]
UPPFELDT, G [1 ]
机构
[1] KAROLINSKA INST,DEPT PSYCHIAT & PSYCHOL,S-10401 STOCKHOLM 60,SWEDEN
关键词
PET; D2-DOPAMINE RECEPTORS; NEUROLEPTIC DRUGS; SCHIZOPHRENIA; DRUG EFFECTS (HUMAN) (RACLOPRIDE);
D O I
10.1016/0006-3223(93)90288-O
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The relationship between central D2-dopamine receptor occupancy and antipsychotic drug effects was examined in a double-blind study. Raclopride was the compound used to induce a selective occupancy of the D2-dopamine receptors. In addition, C-11-labeled raclopride was the radioligand used to measure occupancy by positron emission tomography (PET). Seventeen schizophrenic patients were randomly assigned to one of three parallel groups treated for 4 weeks with daily doses of 2, 6, or 12 mg of raclopride. D2-receptor occupancy was determined by PET at steady-state conditions in 13 patients who completed the study. A statistically significant relationship was demonstrated between antipsychotic effect and degree of D2-receptor occupancy (p < 0.05). Patients with extrapyramidal side effects had significantly higher D2-receptor occupancy than those without (p = 0.02). The finding of a relationship between selective occupancy of the D2-dopamine receptors and clinical effects in schizophrenic patients principally provides new support for the dopamine hypothesis of antipsychotic drug action.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 44 条
  • [1] BALDESSARINI RJ, 1988, ARCH GEN PSYCHIAT, V45, P79
  • [2] A RATING-SCALE FOR DRUG-INDUCED AKATHISIA
    BARNES, TRE
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 : 672 - 676
  • [3] STRIATAL DOPAMINE RECEPTOR OCCUPANCY DURING AND FOLLOWING WITHDRAWAL FROM NEUROLEPTIC TREATMENT - CORRELATIVE EVALUATION BY POSITRON EMISSION TOMOGRAPHY AND PLASMA PROLACTIN LEVELS
    BARON, JC
    MARTINOT, JL
    CAMBON, H
    BOULENGER, JP
    POIRIER, MF
    CAILLARD, V
    BLIN, J
    HURET, JD
    LOCH, C
    MAZIERE, B
    [J]. PSYCHOPHARMACOLOGY, 1989, 99 (04) : 463 - 472
  • [4] HEAD FIXATION DEVICE FOR REPRODUCIBLE POSITION ALIGNMENT IN TRANSMISSION CT AND POSITRON EMISSION TOMOGRAPHY
    BERGSTROM, M
    BOETHIUS, J
    ERIKSSON, L
    GREITZ, T
    RIBBE, T
    WIDEN, L
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1981, 5 (01) : 136 - 141
  • [5] DETERMINATION OF OBJECT CONTOUR FROM PROJECTIONS FOR ATTENUATION CORRECTION IN CRANIAL POSITRON EMISSION TOMOGRAPHY
    BERGSTROM, M
    LITTON, J
    ERIKSSON, L
    BOHM, C
    BLOMQVIST, G
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1982, 6 (02) : 365 - 372
  • [6] BISHOP MP, 1966, ARCH GEN PSYCHIAT, V14, P497
  • [7] INVIVO ASSAY FOR NEUROLEPTIC RECEPTOR-BINDING IN THE STRIATUM - POSITRON TOMOGRAPHY IN HUMANS
    CAMBON, H
    BARON, JC
    BOULENGER, JP
    LOCH, C
    ZARIFIAN, E
    MAZIERE, B
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1987, 151 : 824 - 830
  • [8] ANTIPSYCHOTIC-DRUGS, NEUROTRANSMITTERS, AND SCHIZOPHRENIA
    CARLSSON, A
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1978, 135 (02) : 164 - 173
  • [9] DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS
    CREESE, I
    BURT, DR
    SNYDER, SH
    [J]. SCIENCE, 1976, 192 (4238) : 481 - 483
  • [10] PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS CLINICAL UTILITY
    DAHL, SG
    [J]. CLINICAL PHARMACOKINETICS, 1986, 11 (01) : 36 - 61